Niklas Lindarck

Niklas Lindarck has extensive experience in the pharmaceutical and healthcare sectors, currently serving as the Head of Medical and Payer Evidence Strategy for Cardiovascular Renal Metabolism (CVRM) at AstraZeneca. Previous roles at AstraZeneca include Evidence Lead for Europe & Canada and Medical Evidence Director for the Nordic-Baltic region. Prior to joining AstraZeneca, Niklas held positions as a Clinical Research Associate/Manager and Sales Representative at Draco Läkemedel and worked as a Laboratory Chemist at AkzoNobel. Niklas holds an education from Henley Business School and Umeå University.